Slideshow

5 Classic Hallucinogens Studied in the Treatment of Addictions

Author(s):

Michael P. Bogenschutz, MD

This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.

Related Videos
zoyas222/Adobe Stock
Fedrelina/Adobe Stock
eyetronic/Adobe Stock
Gresel/Adobe Stock
Leo/AdobeStock
Audrey Kuzmin/Adobe Stock
Orawan Pattaramonchai/Adobe Stock
Desemona72/Adobe Stock
2rogan/Adobe Stock
gustavofrazao/Adobe Stock
Related Content
Brigitte Robertson, MD
May 13th 2025

Combating Misconceptions About Alcohol Use Disorder: In Conversation With Brigitte Robertson, MD

Leah Kuntz Brigitte Robertson, MD
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
copilot
April 18th 2025

Copilot and Me and Addiction

Craig T. Pratt, MD, DFASAM, FAPA
Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic
March 19th 2021

Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
smoking
March 27th 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

Heather Burrell Ward, MD
brain
March 24th 2025

Challenges in Treating Acquired Brain Injury

Gary S. Seale, PhD, LPA, LCDC, CBIS-T
© 2025 MJH Life Sciences

All rights reserved.